Objective quantification of BCL2 protein by multiplex immunofluorescence in routine biopsy samples of diffuse large B-cell lymphoma demonstrates associations with survival and

Biopsy Fluorescent Antibody Technique Humans Lymphoma, Large B-Cell, Diffuse / genetics Neoplasm Recurrence, Local Prognosis Proto-Oncogene Proteins c-bcl-2 / genetics Proto-Oncogene Proteins c-myc
BCL2 Diffuse large B-cell lymphoma MYC biomarkers image analysis immunofluorescence

Journal

Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 17 1 2020
medline: 29 4 2021
entrez: 17 1 2020
Statut: ppublish

Résumé

Up-regulation of

Identifiants

DOI: 10.1080/10428194.2020.1713318 PMID: 31942813
pubmed: 31942813
doi: 10.1080/10428194.2020.1713318
doi:

Substances chimiques

BCL2 protein, human 0
Proto-Oncogene Proteins c-bcl-2 0
Proto-Oncogene Proteins c-myc 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1334-1344

Auteurs

Lina Chen (L)

Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada.

Kathrin Tyryshkin (K)

Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada.

Alison Moore (A)

Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada.

David W Scott (DW)

BC Cancer Agency Centre for Lymphoid Cancer, Vancouver, Canada.

Christian Steidl (C)

BC Cancer Agency Centre for Lymphoid Cancer, Vancouver, Canada.

Yi Li (Y)

Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada.

Lois E Shepherd (LE)

Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada.
Canadian Cancer Trials Group, Kingston, Canada.

Michael Rauh (M)

Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada.

Lan Deng (L)

Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada.

David Good (D)

Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada.

Shakeel Virk (S)

Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada.

Bingshu E Chen (BE)

Canadian Cancer Trials Group, Kingston, Canada.

Susan Crocker (S)

Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada.

Tara Baetz (T)

Department of Medical Oncology, Queen's University, Kingston, Canada.

David P LeBrun (DP)

Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Techniques d'investigation › Techniques cytologiques › Cytodiagnostic › Biopsie › Objective quantification of BCL2 protein by...
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Technique d'immunofluorescence › Objective quantification of BCL2 protein by...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Objective quantification of BCL2 protein by...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Lymphomes › Lymphome malin non hodgkinien › Lymphome B › Lymphome B diffus à grandes cellules › Objective quantification of BCL2 protein by...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Processus néoplasiques › Récidive tumorale locale › Objective quantification of BCL2 protein by...
questionsmedicales.fr › Diagnostic › Pronostic › Objective quantification of BCL2 protein by...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines tumorales › Protéines oncogènes › Protéines proto-oncogènes › Protéines proto-oncogènes c-bcl-2 › Objective quantification of BCL2 protein by...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Facteurs de transcription › Facteurs de transcription à motif basique hélice-boucle-hélice › Protéines proto-oncogènes c-myc › Objective quantification of BCL2 protein by...